American Molecular Laboratories
American Molecular Laboratories (AML) is a state-of-the-art molecular diagnostic and biotech development company dedicated to providing high-quality testing. Located in Chicago’s north suburbs, AML utilizes molecular analytic tools and methodologies to design, develop, and implement cutting-edge diagnostic medicine solutions. The company focuses on the diagnosis of infection, disease, and early detection cancer screening, primarily in the gastrointestinal tract. AML provides testing services and products to hospitals, clinics, labs, and major pharmaceutical companies, serving in drug development and research.
Industries
Nr. of Employees
small (1-50)
American Molecular Laboratories
Vernon Hills, Illinois, United States, North America
Products
H. pylori antibiotic resistance panel
A sequencing-based panel for detection of H. pylori and identification of antibiotic resistance markers from clinical stool samples.
Multiplex respiratory pathogen panel
A laboratory panel for simultaneous detection of influenza A/B, RSV, and SARS-CoV-2 from respiratory specimens.
Non-invasive GI cancer screening test
A stool-based molecular test intended for early detection of gastrointestinal cancers.
H. pylori antibiotic resistance panel
A sequencing-based panel for detection of H. pylori and identification of antibiotic resistance markers from clinical stool samples.
Multiplex respiratory pathogen panel
A laboratory panel for simultaneous detection of influenza A/B, RSV, and SARS-CoV-2 from respiratory specimens.
Non-invasive GI cancer screening test
A stool-based molecular test intended for early detection of gastrointestinal cancers.
Services
H. pylori testing and antibiotic resistance panel
Diagnostic testing of stool samples for H. pylori and sequencing-based antibiotic resistance profiling.
Gastrointestinal infection testing
Laboratory testing for a range of gastrointestinal pathogens using molecular methods.
Urinary tract infection testing
Molecular diagnostic testing services for urinary tract infections.
Multiplex respiratory pathogen panel (Influenza/RSV/SARS-CoV-2)
Simultaneous detection of influenza, respiratory syncytial virus (RSV), and SARS-CoV-2 using a multiplex panel.
SARS-CoV-2 (COVID-19) testing
Diagnostic testing services for SARS-CoV-2 using molecular methods.
Non-invasive cancer screening
Development and provision of non-invasive testing approaches for early detection of gastrointestinal cancers using molecular analyses.
H. pylori testing and antibiotic resistance panel
Diagnostic testing of stool samples for H. pylori and sequencing-based antibiotic resistance profiling.
Gastrointestinal infection testing
Laboratory testing for a range of gastrointestinal pathogens using molecular methods.
Urinary tract infection testing
Molecular diagnostic testing services for urinary tract infections.
Multiplex respiratory pathogen panel (Influenza/RSV/SARS-CoV-2)
Simultaneous detection of influenza, respiratory syncytial virus (RSV), and SARS-CoV-2 using a multiplex panel.
SARS-CoV-2 (COVID-19) testing
Diagnostic testing services for SARS-CoV-2 using molecular methods.
Non-invasive cancer screening
Development and provision of non-invasive testing approaches for early detection of gastrointestinal cancers using molecular analyses.
Expertise Areas
- Molecular diagnostics
- Clinical laboratory testing for infectious diseases
- Antimicrobial resistance testing
- Non-invasive cancer screening
Key Technologies
- Next-generation sequencing (NGS)
- PCR-based molecular assays
- Multiplex respiratory panels
- Stool-based diagnostic testing